Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 130 | 2 | 157 | +29 |
| Shares | 58.7M | 598.1K | 71.3M | +13.2M (+22.8%) |
| Value | $700.3M | $7.07M | $415.4M | −$277.9M (−40.1%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (9)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Great Point Partners LLC | 1,000,000 | $11.9M |
| Boxer Capital, LLC | 650,000 | $7.76M |
| Trexquant Investment LP | 120,093 | $1.43M |
| Soleus Capital Management, L.P. | 103,500 | $1.24M |
| Jump Financial, LLC | 63,041 | $752.7K |
| Deerfield Management Company, L.P. (Series C) | 33,296 | $397.6K |
| Dynamic Technology Lab Private Ltd | 19,894 | $238.0K |
| Fortitude Family Office, LLC | 319 | $3.81K |
| Lindbrook Capital, LLC | 41 | $490 |
Not filed for Q4 2024 yet (2)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 535,000 | $6.39M |
| ClariVest Asset Management LLC | 63,149 | $683.3K |